FDA authorizes Novavax's updated COVID-19 vaccine
The U.S. Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax's COVID shot. The updated vaccine is authorized for use in individuals 12 years of age and older and will target the JN.1 strain of the virus.
GlobalData on MSN19d
Novavax wins FDA emergency approval for updated Covid-19 vaccineNovavax has joined its peers and received emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) ...
The newly approved vaccine targets multiple circulating variants, promising enhanced protection and availability across ...
Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...
Welcome to the 26th Annual H.C. Wainwright Global Investment Conference. Our next company presenting are -- that we're having a chat today is Novavax, company that by now, hopefully, all of you know ...
Wayfair (W) stock price has remained under pressure in the past few years as concerns about weak consumer spending remain. It ...
The summer surge of COVID-19 has been decreasing in Sonoma County in early September, but the county’s health officer warns ...
Toronto International Film Festival CEO Cameron Bailey will be honoured at The Black Academy’s third annual Legacy Awards ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback